Speaker(s): 

Thomas P. Olenginski MD, Staff Member, Geisinger - Speakers Bureau & Consultant/Advisor: Amgen

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

  • Appraise the changes seen in 25 years of Geisinger Osteoporotic Care
  • Outline Persistent Care Gaps
  • Highlight the 7 High Risk Groups, where Treatment is Indicated
  • Summarize Available Treatments 
  • Recognize "New Approaches" to Osteoporosis Prevention
  • Emphasize Need for "Individualized Therapy"

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Stefanie Leader, DO, Stanley Martin, MD, Dan Dometita, DO, Malachi Courtney, MD, Eric Hossler, DO, Stacey Coolbaugh, RDN, and Donald Weider, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 
Natalie Stinton, DMD, and Rebecca Stoudt, DNP, PhD, CRNA
 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None

Session date: 
03/06/2026 - 12:00pm to 1:00pm EST
Location: 
Virtual via Microsoft Teams
Danville, PA 17822
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 CDR
  • 1.00 Participation Credit
Please login or register to take this course.